GHRP-2
Growth Hormone Releasing Peptide-2
GHRP-2 (Growth Hormone Releasing Peptide-2), also known as pralmorelin, is a synthetic hexapeptide that acts as a potent agonist at the ghrelin/growth hormone secretagogue receptor (GHS-R). It triggers pulsatile growth hormone release from the pituitary gland, mimicking the body's natural GH secretion patterns. GHRP-2 was developed as a diagnostic agent and is clinically approved in Japan for assessing growth hormone deficiency. Unlike direct GH administration, GHRP-2 works through the body's natural pathways, making it a preferred option for those seeking to enhance their natural growth hormone production safely and effectively.
Complete Dosing Guide
Possible Side Effects
Common Side Effects (Generally Mild):
- Increased appetite (35-40% increase in food intake)
- Water retention/mild edema
- Tingling or numbness in extremities
- Mild joint stiffness
- Facial flushing (immediately post-injection)
- Injection site reactions
Less Common Side Effects:
- Elevated cortisol (at higher doses)
- Increased prolactin (dose-dependent)
- Lethargy or fatigue
- Decreased insulin sensitivity
- Headaches
⚠️ Rare but Serious:
- Severe hypoglycemia (if combined with insulin)
- Significant water retention
- Exacerbation of carpal tunnel syndrome
Medical Disclaimer
Clinical data presented is from peer-reviewed studies. Individual results may vary. Consult healthcare professionals before starting treatment. This information is for educational purposes only.